Skip to content
Medical Health Aged Care, Research Development

Techcracker Lab Showcase: Breakthrough Medtech and Deep Tech at UNSW

UNSW Sydney 2 mins read

UNSW Sydney and Horizons Ventures invite media to attend the Techcracker Lab showcase, a free event on Friday 14 November at UNSW’s Kensington campus.

The showcase will highlight breakthrough technologies and the visionary founders behind them from around the world, including US-based HistoSonics, which will demonstrate its new FDA-approved histotripsy technology. This non-invasive therapy destroys cancer tumour tissue using pulsed sound waves.

Watch a video demonstration of the technology here.

The inventor of HistoSonics, Li Ka Shing Endowed Professor of Biomedical Engineering at the University of Michigan, Professor Xu Zhen, will be available for media interviews.

Solina Chau, co-founder of Hong Kong-based venture capital firm Horizons Ventures and Director of the Li Ka Shing Foundation, will appear at the event alongside UNSW Chancellor David Gonski AC. The program will be hosted by Professor Bronwyn Fox AO, UNSW Deputy Vice-Chancellor (Research & Enterprise).

Speakers from Horizons Ventures’ portfolio companies, including Harrison.ai, MEandMINE, Holoclara and HistoSonics, will share insights into how deep tech founders and investors navigate innovation, scale and global impact.

A key feature of Techcracker Lab is the Medtech Expo, showcasing UNSW’s most promising start-ups. As Australia’s number one university for founders, UNSW is proud to present ventures emerging from its world-class research and entrepreneurial ecosystem.

 

Event details

When: Friday 14 November, 2:00–5:15pm (Tech Expo and refreshments 5:15–6:30pm)

Where: Leighton Hall, John Niland Scientia Building, UNSW Kensington Campus

Cost: Free (registration essential)

 

Speakers:

  • Professor Xu Zhen, inventor of histotripsy
  • Solina Chau, co-founder of Horizons Ventures and Director of the Li Ka Shing Foundation
  • David Gonski AC, Chancellor, UNSW Sydney
  • Professor Bronwyn Fox AO, Deputy Vice-Chancellor (Research & Enterprise), UNSW Sydney


Media contacts
Julia Holman, UNSW Sydney, +61 435 124 673

Ryan Fung, H.S. Chau Foundation, +852 6683 1313


Contact details:

Julia Holman, UNSW Sydney, +61 435 124 673

Ryan Fung, H.S. Chau Foundation, +852 6683 1313

Media

More from this category

  • Medical Health Aged Care
  • 23/03/2026
  • 10:48
Public Health Association of Australia

Preventive Mental Health Conference aims to shift debate from niche to the mainstream

23 March 2026 Experts from across Australia and overseas will gather inParramatta from tomorrow to present research, share ideas, and work together to promote and protect the mental health and wellbeing of people across the country. Organised by the Public Health Association and Prevention United, the Preventive Mental Health Conference runs 24-25 March at the Novotel Parramatta. Media are welcome to attend, and various presenters are available for interview. Speakers will include Commissioner Dr Angela Jackson from the Productivity Commission, Everymind’s Director, Dr Jaelea Skehan OAM, and Associate Professor Clinton Schultz, Director First Nations Strategy and Partnerships at the Black…

  • Contains:
  • Medical Health Aged Care
  • 23/03/2026
  • 07:58
Royal Australian College of GPs

Spiralling hospital costs show NSW health budget desperate for a cure: RACGP

With NSW hospital spending surging by more than 60% since 2014, the Royal Australian College of GPs (RACGP) has called on the State Government to work with GPs to bring costs under control in its 2026–27 NSW pre-budget submission. RACGP NSW&ACT Chair Dr Rebekah Hoffman said “completely unsustainable” hospital costs show change is needed. “Over the last 10 years, the cost of the NSW public hospital system has increased by more than 60%,” she said. “That’s completely unsustainable. It’s a symptom of a sick healthcare system that’s struggling under the burdens of an ageing population, an epidemic of chronic disease,…

  • Contains:
  • Medical Health Aged Care, Seniors Interest
  • 23/03/2026
  • 06:30
CSL Seqirus

Adjuvanted flu vaccine, Fluad, approval extended to Australians aged 50 and over

Melbourne,16March 2026–Fluad, an adjuvantedinfluenza(flu)vaccine,has now been approved for Australians aged 50and over. Fluadhas beenfundedin Australiasince 2018foradults aged 65 and over on the NationalImmunisationProgram.1In that…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.